Rehabilitation in Practice: Neurogenic lower urinary tract dysfunction and its management

Clinical Rehabilitation

Volumn 24, Issue 7, 2010, Pages 579-589

  Panicker, Jalesh n ^a   de Sze, Marianne ^b   Fowler, Clare j ^b  

^a B VERKIN INSTITUTE FOR LOW TEMPERATURE PHYSICS AND ENGINEERING   (Ukraine)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MICTURITION DISORDER; NEUROGENIC BLADDER; PATHOPHYSIOLOGY; REVIEW;

HUMANS; URINARY BLADDER, NEUROGENIC; URINATION DISORDERS;

EID: 77954117584     PISSN: 02692155     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269215509353252     Document Type: Article

References (41)

1. Craggs MD, Vaizey CJ Neurophysiology of the bladder and bowel. In Fowler CJ. ed. Neurology of bladder, bowel and sexual dysfunction. Boston: Butterworth-Heinemann, 1999: 19-31.
2. Panicker JN Bladder and bowel dysfunction following neurological disease. Medicine 2008; 32: 620-23.
3. Norris JP, Staskin DR History, physical examination and classification of neurogenic voiding dysfunction. Urol Clin North Am 1996; 23: 337-43.
4. Abrams P., Agarwal M., Drake M. et al. A proposed guideline for the urological management of patients with spinal cord injury. BJU Int 2008; 101: 989-94.
5. Stohrer M., Castro-Diaz D., Chartier-Kastler E., Kramer G., Mattiasson A., Wyndaele JJ Guidelines on neurogenic lower urinary tract dysfunction. Prog Urol 2007; 17: 703-55.
6. Ruffion A., de Seze M., Denys P., Perrouin-Verbe B., Chartier-Kastler E. [Groupe d’Etudes de Neuro-Urologie de Langue Francaise (GENULF) guidelines for the management of spinal cord injury and spina bifida patients]. Prog Urol 2007; 17: 631-33.
7. Fowler CJ, Panicker JN, Drake M. et al. A UK consensus on the management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry 2009; 80: 470-77.
8. de Seze M., Ruffion A., Denys P., Joseph PA, Perrouin-Verbe B. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler 2007; 13: 915-28.
9. Webster GD, Guralnick MD The neurourologic evaluation. In Walsh PC. ed. Campbell's urology. Philadelphia: Saunders, 2002.
10. Abrams P., Cardozo L., Fall M. et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78.
11. Betts CD, D’Mellow MT, Fowler CJ Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993; 56: 245-50.
12. Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn 1995; 14: 131-39.
13. Shumaker SA, Wyman JF, Uebersax JS, McClish D., Fantl JA Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res 1994; 3: 291-306.
14. Haab F., Richard F., Amarenco G. et al. Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire. Urology 2008; 71: 646-56.
15. Donovan J., Bosch R., Gotoh M. et al. Symptom and quality of life assessment. In Abrams P, Cardozo L, Khoury S, Wein A. eds. Incontinence, Vol 1. Paris: Health Publications, 2005: 519-84.
16. Bonniaud V., Bryant D., Parratte B., Guyatt G. Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen. J Urol 2008; 180: 2592-98.
17. Acquadro C., Kopp Z., Coyne KS, Corcos J., Tubaro A., Choo MS, Oh SJ Translating overactive bladder questionnaires in 14 languages. Urology 2006; 67: 536-40.
18. Fowler CJ, O’Malley KJ Investigation and management of neurogenic bladder dysfunction. J Neurol Neurosurg Psychiatry 2003; 74(suppl 4): iv27-iv31.
19. Abrams P. Urodynamics. London: Springer-Verlag, 2006.
20. Sirls LT, Zimmern PE, Leach GE Role of limited evaluation and aggressive medical management in multiple sclerosis: a review of 113 patients. J Urol 1994; 151: 946-50.
21. Prasad RS, Smith SJ, Wright H. Lower abdominal pressure versus external bladder stimulation to aid bladder emptying in multiple sclerosis: a randomized controlled study. Clin Rehabil 2003; 17: 42-47.
22. O’Riordan JI, Doherty C., Javed M., Brophy D., Hutchinson M., Quinlan D. Do alpha-blockers have a role in lower urinary tract dysfunction in multiple sclerosis? J Urol 1995; 153: 1114-16.
23. Naumann M., So Y., Argoff CE et al. Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008; 70: 1707-14.
24. Vahter L., Zopp I., Kreegipuu M., Kool P., Talvik T., Gross-Paju K. Clean intermittent self-catheterization in persons with multiple sclerosis: the influence of cognitive dysfunction. Mult Scler 2009; 15: 379-84.
25. Srikrishna S., Robinson D., Cardozo L., Vella M. Management of overactive bladder syndrome. Postgrad Med J 2007; 83: 481-86.
26. De Wachter S., Wyndaele JJ Intravesical oxybutynin: a local anesthetic effect on bladder C afferents. J Urol 2003; 169: 1892-95.
27. Chapple CR, Khullar V., Gabriel Z., Muston D., Bitoun CE, Weinstein D. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 2008; 54: 543-62.
28. Novara G., Galfano A., Secco S. et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 2008; 54: 740-64.
29. Kinn AC, Larsson PO Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis. Scand J Urol Nephrol 1990; 24: 109-12.
30. Horowitz M., Combs AJ, Gerdes D. Desmopressin for nocturnal incontinence in the spina bifida population. J Urol 1997; 158: 2267- 68.
31. Bosma R., Wynia K., Havlikova E., De Keyser J., Middel B. Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis. Acta Neurol Scand 2005; 112: 1-5.
32. Fowler CJ, Beck RO, Gerrard S., Betts CD, Fowler CG Intravesical capsaicin for treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry 1994; 57: 169-73.
33. de Seze M., Wiart L., Joseph PA, Dosque JP, Mazaux JM, Barat M. Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn 1998; 17: 513-23.
34. Giannantoni A., Di Stasi SM, Stephen RL et al. Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. J Urol 2002; 167: 1710-14.
35. Schurch B., de Seze M., Denys P. et al. Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005; 174: 196-200.
36. Kalsi V., Gonzales G., Popat R. et al. Botulinum injections for the treatment of bladder symptoms of multiple sclerosis. Ann Neurol 2007; 62: 452-57.
37. Ehren I., Volz D., Farrelly E. et al. Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind study. Scand J Urol Nephrol 2007; 41: 335-40.
38. Wallace PA, Lane FL, Noblett KL Sacral nerve neuromodulation in patients with underlying neurologic disease. Am J Obstet Gynecol 2007; 197: 96e91-95.
39. Chartier-Kastler EJ, Bosch RJL, Perrigot M., Chancellor MB, Richard F., Denys P. Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J Urol 2000; 164: 1476-80.
40. Kabay SC, Yucel M., Kabay S. Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with multiple sclerosis: urodynamic study. Urology 2008; 71: 641-45.
41. Hess MJ, Hess PE, Sullivan MR, Nee M., Yalla SV Evaluation of cranberry tablets for the prevention of urinary tract infections in spinal cord injured patients with neurogenic bladder. Spinal Cord 2008; 46: 622-26.